Screener
Charles River Laboratories CRL Goodwill Additions
Goodwill Additions at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | RMS | DSA (1) | Manufacturing (2) | Total |
|---|---|---|---|---|
| December 27, 2025 | $510,844 | $1,678,518 | $574,891 | $2,764,253 |
| Acquisitions | — | 335,906 | 39,786 | 375,692 |
| Divestitures | — | (37,701) | — | (37,701) |
| Foreign exchange | (551) | (19,320) | (5,522) | (25,393) |
| June 27, 2026 | $510,293 | $1,957,403 | $609,155 | $3,076,851 |
| (1) DSA includes accumulated impairment losses of $1 billion, which were recognized in fiscal years 2008 and 2010. | ||||
| (2) Manufacturing includes accumulated impairment losses of $380 million, which were recognized in fiscal years 2024 and 2025. |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's goodwill additions?
- Charles River Laboratories (CRL) reported goodwill additions of $34.71M in Q2 2026.
- What does goodwill additions mean?
- Represents the value of goodwill recognized during the period as a result of business combinations and acquisitions. This metric indicates the company's inorganic growth strategy and the premium paid for acquired assets. It is a key indicator of capital allocation toward external expansion.
Ask your AI about Charles River Laboratories's goodwill additions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude